GB1153347A - Imidazole Derivatives, their preparation and Compositions containing them. - Google Patents

Imidazole Derivatives, their preparation and Compositions containing them.

Info

Publication number
GB1153347A
GB1153347A GB29846/66A GB2984666A GB1153347A GB 1153347 A GB1153347 A GB 1153347A GB 29846/66 A GB29846/66 A GB 29846/66A GB 2984666 A GB2984666 A GB 2984666A GB 1153347 A GB1153347 A GB 1153347A
Authority
GB
United Kingdom
Prior art keywords
nitroimidazole
reaction
general formula
alkyl
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB29846/66A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB1153347A publication Critical patent/GB1153347A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • C07D233/94Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Abstract

1,153,347. Imidazole derivatives. MERCK & CO. Inc. 4 July, 1966 [7 July, 1965; 18 May, 1966], No. 29846/66. Heading C2C. Novel imidazole derivatives of the general formula wherein R 1 is alkyl or substituted alkyl wherein said substituent is aryl, fluorophenyl, nitrophenyl, oxo, alkenyl, hydroxy, halo, alkanoyloxy, aralkanoyloxy, benzoyloxy, alkoxy, aralkoxy, carboxy, carboalkoxy, carboaralkoxy, alkylcarbamoyl, aralkylcarbamoyl, dialkylcarbamoyl, arylcarbamoyl, carbamoyloxy, carbamoyl, cyano, alkylthio, aralkylthio, arylthio, alkylsulphinyl, aralkylsulphinyl, arylsulphinyl, alkylsulphonyl, aralkylsulphonyl, arylsulphonyl or dialkylamino; Q is C 1-5 alkylene, C 3-5 alkenylene, aralkylidene or C 2-5 alkylidene; W is nitro, cyano, phenyl or hydrogen; and P is hydrogen or nitro; provided that one and only one of W and P is nitro; and T has the structure wherein A is oxygen or sulphur; M is oxygen, sulphur, imino or alkylimino; R 3 and R 4 are each hydrogen, alkyl or substituted alkyl, wherein the substituent(s) is/are halo, hydroxy, alkoxy, oxo, aryl and oxo, carboxy, carboalkoxy, carboaralkoxy, carbamoyloxy, alkanoyloxy, aralkanoyloxy, carbamoyl, alkylcarbamoyl, arylcarbamoyl, aralkylcarbamoyl, dialkylcarbamoyl, sulphamoyl, alkylsulphamoyl, arylsulphamoyl, aralkylsulphamoyl, dialkylsulphamoyl, mercapto, alkylthio, aralkylthio, thioncarbamoyl, dialkylthiocarbamoylthio, diaralkylthiocarbamoylthio, amino, alkylamino, dialkylamino, diaralkylamino or heterocycloalkyl in which the ring contains at least one nitrogen atom, which is bonded to the alkyl group; phenyl, nitrophenyl, chlorophenyl, fluorophenyl, substituted methylene or alkylidene in which the substituent(s) is/are alkoxy, aralkoxy, aryloxy, dialkylamino or diaralkylamino; alkanoyl, aralkanoyl, aroyl, cyanoalkanoyl or C 3-5 alkenoyl; hydroxy, substituted hydroxy wherein said substituent is alkanoyl, aralkanoyl, aroyl, alkyl, aralkyl, aryl, cyanoalkanoyl or C 3-5 alkenoyl; carbamoyl and thiocarbamoyl and N-substituted carbamoyl and thiocarbamoyl wherein said substituent is alkyl, aralkyl or aryl; heterocycloalkylcarbonyl in which the heterocycloalkyl ring contains at least one nitrogen atom, which is bonded to the carbonyl group; nitro, amino and substituted amino, in which the substituent(s) is/are carbamoyl, thiocarbamoyl, C 2-5 alkylidene, aralkylidene, alkanoyl, aralkanoyl, aroyl, cyanoalkanoyl or C 3-6 alkenoyl; alkanoylalkanoyloxy, aralkanoylaralkanoyloxy, sulphamoyl, alkylsulphamoyl, dialkylsulphamoyl, aralkylsulphamoyl, diaminophosphoryl, bis(alkylamino)- phosphoryl, bis(dialkylamino)phosphoryl, bis (phenylamino)phosphoryl and bis(diphenylamino)phosphoryl; or R 3 and R 4 together represent a -(CH 2 ) 2 R 5 (CH 2 ) 2 - group, where R 5 is oxygen, sulphur, methylene, imino, alkylimino or a carbon-to-carbon single bond; the terms " alkyl," " alkanoyl " and " alkoxy " meaning such groups containing from 1 to 5 carbon atoms, are prepared by the following general processes: (i) reaction of an isocyanate or isothiocyanate of the general formula R 3 -N-C=M with an imidazole derivative of the general formula wherein R 1 is not hydroxyalkyl and, where R 1 is alkanoyloxyalkyl, optional hydrolysis with a base to obtain the product wherein R 1 is hydroxyalkyl; (ii) reaction of an alkali metal cyanate or thiocyanate with an imidazole derivative of the general formula wherein X is halo or alkyl- or phenyl-sulphonyloxy, and R 1 is alkyl or substituted alkyl, where the substituent is oxo, alkenyl, hydroxy, phenylalkoxy, alkoxy, carboxy, alkylthio, phenylalkylthio, alkylsulphinyl, phenylalkylsulphinyl, alkylsulphonyl, phenylalkylsulphonyl or phenylsulphonyl, except that R 1 is not hydroxyalkyl in the starting material, followed by treatment of the resulting cyanate or thiocyanate of the general formula with an acid; (iii) reaction of phosgene or thiophosgene with an imidazole derivative of the fourth general formula above, followed by reaction of the resulting halocarbonate or halothioncarbonate of the general formula wherein X is halo, with ammonia or an amine of the general formula R 3 R 4 NH; (iv) reaction of an imidazole derivative of the fourth general formula above with a carbamoyl halide or alkyl carbamate or thion analogue thereof of the general formula wherein B is halo or alkoxy; (v) reaction of an imidazole derivative of the fourth general formula above with a halocarbonate or halothioncarbonate of the general formula wherein X is halo, followed by reaction of the resulting phenyl carbonate or thioncarbonate of the general formula with ammonia or an amine of the general formula R 3 R 4 NH; and (vi) reaction of an imidazole derivative of the fifth general formula above with a thiourea derivative of the general formula wherein M is imino or alkylimino and X is halo, alkylsulphonyloxy or phenylsulphonyloxy. Pharmaceutical compositions, useful against parasitic diseases, amoebiasis, trypanosomiasis and chronic respiratory diseases in fowl and also having antibacterial activity, comprise as active ingredient an imidazole derivative of the first or second general formula above and a pharmaceutical diluent, carrier or coating. 1 - Methyl - 4 - phenyl - 5 - nitroimidazole is prepared by treatment of 4-p-acetylaminophenyl-5-nitroimidazole with sulphuric acid and sodium nitrite and reaction of the resulting 4 - phenyl - 5 - nitroimidazole with dimethyl sulphate. 1 - n - Methyl - 2 - hydroxymethyl - 4- nitroimidazole is produced by reaction of 2- hydroxymethyl-4-nitroimidazole with dimethyl sulphate. 1 - n - Butyl - and 1 - allyl - 5 - nitroimidazoles are prepared by reaction of 4(5)- nitroimidazole with n-butyl or allyl tosylate, respectively. 1 - (2<SP>1 </SP>- Hydroxyethyl) - 5 - nitroimidazole is prepared by reaction of 4(5)-nitroimidazole with ethylene oxide and is converted to 1 - (2<SP>1 </SP>- acetoxyethyl) - 5 - nitroimidazole by reaction with acetic anhydride. 1-(2<SP>1</SP>-Acetoxypropyl) - 5 - nitroimidazole and 1 - (2<SP>1 </SP>- benzoyloxyethyl) - 5 - nitroimidazole are prepared analogously. 1-Ethoxyethyl-5-nitroimidazole is produced by reaction of 4(5)-nitroimidazole with #-ethoxyethyl tosylate; and 1-ethoxypropyl-5- nitroimidazole is produced analogously. 5-Nitroimidazol-1-yl acetic acid is prepared by oxidation of 1 - (2<SP>1</SP> - hydroxyethyl) - 5 - nitroimidazole with chromic acid/sulphuric acid or with trifluoroacetic acid and dicyclohexylcarbodiimide, and then sodium hypochlorite; or by alkaline hydrolysis of the corresponding ethyl ester. 5- Nitroimidazol-1-yl-acetonitrile is prepared by dehydration of 5-nitroimidazol-1-yl-acetamide with thionyl chloride. 5-Nitroimidazol-1-yl-ethyl ethylsulphone is prepared by treatment of 5-nitroimidazol-1-yl-ethyl p-toluenesulphonate with the potassium salt of ethanethiol, oxidation of the resulting 1 - (2<SP>1 </SP>- ethylthioethyl) - 5 - nitroimidazole with perphthalic acid and further oxidation of the obtained 1-(2<SP>1</SP>-ethylsulphinylethyl) - 5 - nitroimidazole with hydrogen peroxide. 1 - (2<SP>1</SP>- N - morpholinylethyl) - 5 - nitroimidazole is prepared by reaction of 1-(2<SP>1</SP>- hydroxyethyl)-5-nitroimidazole with p-toluenesulphonyl chloride and reaction of the resulting 1 - (2<SP>1</SP>- p - toluenesulphonyloxyethyl)- 5 - nitroimidazole with morpholine. 1 - [(2<SP>1</SP> - Tetrahydropyran - 2<SP>11</SP> - yl - oxy)ethyl] - 2 - hydroxymethyl-5-nitroimidazole is prepared by reaction of 1 - (2<SP>1</SP>- hydroxyethyl) - 5 - nitroimidazole with dihydropyran and paraformaldehyde. 1- Methyl - 2 - chloromethyl - 5 - nitroimidazole is produced by treatment of the corresponding 2- hydroxymethyl compound with thionyl chloride and may be converted to 1-methyl-2-mercaptomethyl-5-nitroimidazole with thiourea and sodium hydroxide. 1 - Methyl - 2 - p - toluenesulphonyloxymethyl - 5 - nitroimidazole, 1- methyl - 5 - nitroimidazol - 2 - yl-methyl phenyl carbonate and 1 - methyl - 5 - nitroimidazol - 2- yl-methyl phenyl thionocarbonate are prepared by reaction of 1-methyl-2-hydroxymethyl-5- nitroimidazole with p-toluenesulphonyl chloride, phenyl chloroformate and phenoxythiocarbonyl chloride, respectively.
GB29846/66A 1965-07-07 1966-07-04 Imidazole Derivatives, their preparation and Compositions containing them. Expired GB1153347A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47023965A 1965-07-07 1965-07-07
US55093266A 1966-05-18 1966-05-18

Publications (1)

Publication Number Publication Date
GB1153347A true GB1153347A (en) 1969-05-29

Family

ID=27043018

Family Applications (5)

Application Number Title Priority Date Filing Date
GB32952/68A Expired GB1155528A (en) 1965-07-07 1966-07-04 Imidazole derivatives, their Preparation and Compositions containing them
GB35039/68A Expired GB1155529A (en) 1965-07-07 1966-07-04 Imidazole derivatives, their Preparation and Compositions containing them
GB35033/68A Expired GB1154290A (en) 1965-07-07 1966-07-04 Imidazole Derivatives, their preparation and compositions containing them
GB29846/66A Expired GB1153347A (en) 1965-07-07 1966-07-04 Imidazole Derivatives, their preparation and Compositions containing them.
GB38884/68A Expired GB1155530A (en) 1965-07-07 1966-07-04 Imidazole Derivatives, their Preparation and Compositions containing them

Family Applications Before (3)

Application Number Title Priority Date Filing Date
GB32952/68A Expired GB1155528A (en) 1965-07-07 1966-07-04 Imidazole derivatives, their Preparation and Compositions containing them
GB35039/68A Expired GB1155529A (en) 1965-07-07 1966-07-04 Imidazole derivatives, their Preparation and Compositions containing them
GB35033/68A Expired GB1154290A (en) 1965-07-07 1966-07-04 Imidazole Derivatives, their preparation and compositions containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB38884/68A Expired GB1155530A (en) 1965-07-07 1966-07-04 Imidazole Derivatives, their Preparation and Compositions containing them

Country Status (18)

Country Link
JP (3) JPS5010865B1 (en)
AT (5) AT291990B (en)
BE (1) BE683796A (en)
BR (1) BR6681050D0 (en)
CH (3) CH562806A5 (en)
CY (1) CY565A (en)
DE (1) DE1620018B2 (en)
DK (1) DK141287B (en)
ES (1) ES329085A1 (en)
FI (1) FI46961C (en)
FR (2) FR1502699A (en)
GB (5) GB1155528A (en)
IL (2) IL25931A (en)
IT (1) IT1061026B (en)
MY (1) MY7100055A (en)
NL (1) NL149793B (en)
NO (1) NO122186B (en)
SE (1) SE343578B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723453A (en) * 1969-06-20 1973-03-27 Rech Et Applic Scient Et Medic 1-(beta-sulphonyloxy-ethyl)-imidazoles
US3968228A (en) * 1973-11-13 1976-07-06 Merck & Co., Inc. 4-Nitro-5-cyanoimidazoles as coccidiostats

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758145A (en) * 1969-10-29 1971-04-28 Smith Kline French Lab ISO-THIO-UREES AND DERIVATIVES
US3678066A (en) * 1970-03-06 1972-07-18 Squibb & Sons Inc Thiocyanic acid esters
JPH02254965A (en) * 1989-03-28 1990-10-15 Chiyoudendou Hatsuden Kanren Kiki Zairyo Gijutsu Kenkyu Kumiai Rotor for superconducting rotary electric machine
WO2016156290A1 (en) * 2015-04-02 2016-10-06 Bayer Cropscience Aktiengesellschaft Novel 5-substituted imidazole derivatives
EP3519389A1 (en) 2016-09-29 2019-08-07 Bayer CropScience Aktiengesellschaft Novel 5-substituted imidazolylmethyl derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5149436B2 (en) * 1971-11-15 1976-12-27

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723453A (en) * 1969-06-20 1973-03-27 Rech Et Applic Scient Et Medic 1-(beta-sulphonyloxy-ethyl)-imidazoles
US3968228A (en) * 1973-11-13 1976-07-06 Merck & Co., Inc. 4-Nitro-5-cyanoimidazoles as coccidiostats

Also Published As

Publication number Publication date
NO122186B (en) 1971-06-01
GB1155530A (en) 1969-06-18
NL6609552A (en) 1967-01-09
FI46961C (en) 1973-08-10
DE1620018A1 (en) 1970-03-05
JPS5010865B1 (en) 1975-04-24
BR6681050D0 (en) 1973-05-15
GB1155529A (en) 1969-06-18
DK141287B (en) 1980-02-18
FI46961B (en) 1973-05-02
CH562806A5 (en) 1975-06-13
AT291989B (en) 1971-08-10
CH565769A5 (en) 1975-08-29
AT291990B (en) 1971-08-10
MY7100055A (en) 1971-12-31
JPS4843909B1 (en) 1973-12-21
BE683796A (en) 1967-01-09
SE343578B (en) 1972-03-13
AT284114B (en) 1970-09-10
AT294487B (en) 1971-11-25
GB1154290A (en) 1969-06-04
IT1061026B (en) 1982-10-20
GB1155528A (en) 1969-06-18
AT291988B (en) 1971-08-10
DE1620018B2 (en) 1976-04-15
IL25931A (en) 1972-01-27
NL149793B (en) 1976-06-15
DK141287C (en) 1980-07-07
FR1502699A (en) 1967-11-24
ES329085A1 (en) 1967-05-01
CH522651A (en) 1972-05-15
FR5890M (en) 1968-03-18
IL35748A0 (en) 1971-01-28
JPS5138718B1 (en) 1976-10-23
CY565A (en) 1970-11-09

Similar Documents

Publication Publication Date Title
GB1282612A (en) Quinazolinones
GB1131191A (en) New imidazole derivatives, their preparation and use
GB1153347A (en) Imidazole Derivatives, their preparation and Compositions containing them.
GB1402498A (en) Triazine derivatives their production and their medicinal use
GB1331710A (en) 1,2,3,4-tetrahydroisoquinolines
GB1176310A (en) Aryl-Sulphonyl-Semicarbazides
GB1531924A (en) Carbamylguanidine antimicrobial compounds
IL41848A (en) 1-substituted-3-(1,2,3-thiadiazol-5-yl)urea derivatives
GB1155937A (en) Novel Oxazolidinones
ES338168A1 (en) 1,2,4-oxadiazolidines
GB1459506A (en) Piperidine derivatives
GB1125559A (en) Novel urea derivatives and their production
GB1471615A (en) Morpholinothiooxamide derivatives and their use in vulcani zable rubber compositions
SE7413856L (en)
GB1315849A (en) 1,2,3-trithiane derivatives
GB1291762A (en) Novel n,n-disubstituted ureas and thioureas, processes for their preparation, and compositions incorporating them
GB1185039A (en) Pyrimidine Derivatives and Compositions containing them
GB1203430A (en) Heterocyclic spiro compounds
GB1161062A (en) Active Sulphonamides
GB1374365A (en) Nitrosourea derivatives
GB1250353A (en)
GB1466924A (en) Indazole derivatives
GB1353892A (en) Nitroimidazolyl-triazolo-pyridazines
GB1385695A (en) 2,6-dichlorobenzaldoxime-o- s-triazinyl-6-ethers and their use as herbicidal agents
GB1273277A (en) N-acyl-p-tertiaryaminophenylhydrazones and processes for their preparation

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE Patent expired